Introducing Enstilar
A once-daily, 4 week topical combination treatment in a foam spray formulation for the treatment of adult plaque psoriasis.1
Enstilar® is effective
at achieving plaque
clearance at week 4.2
Application
once daily.1
Efficacy
Enstilar® is more effective
than its individual active components
in achieving plaque clearance2
Enstilar® treatment over 4 weeks
For illustrative purposes only. Images are of a representative individual psoriasis patient from the PSO-FAST study (DoF: LEO90100 003). Images are of a patient’s hip. Individual results may vary.3
How to use Enstilar®
Shake for a few seconds
before use1
Spray on to the skin from
at least 3cm distance1
Apply to the affected areas
and rub gently into the skin1
A guide to prescribing Enstilar®
As an example, for moderate plaque psoriasis affecting a body surface area of 5-8%, prescribe
2 x 60g cans and refer to the prescribing information for dosing specifics.1
When using Enstilar® the total dose of calcipotriol containing products should not exceed 15g per day and the total body surface area treated should not exceed 30%.1
- Enstilar Summary of Product Characteristics. 2018.
- Lebwohl M., Tyring S., Bukhalo M. et al. Fixed Combination Aerosol Foam Calcipotriene 0.005% (Cal) Plus Betamethasone Dipropionate 0.064% (BD) is More Efficacious than Calor BD Aerosol Foam Alone for Psoriasis Vulgaris. J Clin Aesthet Dermatol 2016; 9 (2): 34-41.
- Leonardi G., Bagel J., Yamauchi P. et al. Efficacy and Safety of Calcipotriene Plus Betamethasone Dipropionate Aerosol Foam in Patients With Psoriasis Vulgaris– a Randomized Phase III Study (PSO-FAST). J Drugs Dermatol. 2015; 14 (12): 1468-1477.
